Posted on May 15, 20255/15/25
From Science to Value: Strategic Asset Valuation for Biotech Licensing and Fundraising
Posted on May 5, 20255/5/25
Harnessing the Digital Voice: High-Impact Social Listening for Pharma in the Diverse APAC Landscape
Posted on April 11, 20254/11/25
Unlocking Pharma Success: Mike Ryan’s Pre-Conference Talk at Reuters Pharma 2025
Posted on April 4, 20254/4/25
CASE STUDY: Transforming Clinical Trials with EVERSANA
Posted on April 3, 20254/3/25
Generic Substitution in Southeast Asia and Emerging Markets: Key Insights for Strategic Decision-Making
Posted on March 19, 20253/19/25
Maximizing Sales with AI: A Strategic Roadmap for Success
Posted on March 19, 20253/19/25
Rare Disease Care in India: A Path to Positive Impact
Posted on February 28, 20252/28/25
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Posted on February 27, 20252/27/25
Securing Launch Success Within the Context of the New EU Health Technology Assessment Regulation (HTAR) Landscape in Europe
Posted on February 21, 20252/21/25